Coya Therapeutics Inc — Cash Flow (NASDAQ:COYA) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -7.24 M-11.19 M-10.29 M -12.14 M Cash from investing activities -525 K-543.19 K-25 K — Cash from financing activities 9.36 M38.43 M16.03 M 9.73 M Free cash flow -7.24 M-11.19 M-10.29 M -12.14 M

Notizie

H.C. Wainwright conferma il rating Buy su Coya Therapeutics con target di $18

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target

Coya Therapeutics ottiene 11,1 milioni di dollari tramite posizionamento privato

Coya Therapeutics secures $11.1 million in private placement

Coya Therapeutics advances ALS and FTD clinical trials in 2026

H.C. Wainwright conferma rating Buy su Coya Therapeutics con target a $18

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18

Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)

H.C. Wainwright conferma il rating Buy sulle azioni di Coya Therapeutics

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock

H.C. Wainwright riconferma il rating Buy sulle azioni di Coya Therapeutics con target di $18

H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target